conversion of semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are switch to tirzepatide from semaglutide

Compounded versions became a viable option for those unable to access the branded medications

However, there are those who, despite their diet and exercise attempts

$99 /month (excludes medication) Dosage determined by your prescribing provider

Richard Braga Device SRM/CDMO Lead, Takeda Pharmaceuticals A seasoned leader with over 25 years of experience in medical device development, including the past decade dedicated to combination product development

However, the authors included only six RCTs involving tirzepatide and, as opposed to our meta-analysis, did not provide information on comparative effects across different doses of the two medications [55]